These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 21937869

  • 1. The effect of pramipexole on depressive symptoms in Parkinson's disease.
    Yasui N, Sekiguchi K, Hamaguchi H, Kanda F.
    Kobe J Med Sci; 2011 Feb 02; 56(5):E214-9. PubMed ID: 21937869
    [Abstract] [Full Text] [Related]

  • 2. Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial.
    Barone P, Poewe W, Albrecht S, Debieuvre C, Massey D, Rascol O, Tolosa E, Weintraub D.
    Lancet Neurol; 2010 Jun 02; 9(6):573-80. PubMed ID: 20452823
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Depressive illness in Parkinson's disease--indication of a more advanced and widespread neurodegenerative process?
    Pålhagen SE, Carlsson M, Curman E, Wålinder J, Granérus AK.
    Acta Neurol Scand; 2008 May 02; 117(5):295-304. PubMed ID: 18279483
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Anhedonia, depression, and motor functioning in Parkinson's disease during treatment with pramipexole.
    Lemke MR, Brecht HM, Koester J, Kraus PH, Reichmann H.
    J Neuropsychiatry Clin Neurosci; 2005 May 02; 17(2):214-20. PubMed ID: 15939976
    [Abstract] [Full Text] [Related]

  • 14. Twice-daily, low-dose pramipexole in early Parkinson's disease: a randomized, placebo-controlled trial.
    Kieburtz K, Parkinson Study Group PramiBID Investigators.
    Mov Disord; 2011 Jan 02; 26(1):37-44. PubMed ID: 20925067
    [Abstract] [Full Text] [Related]

  • 15. Characteristics of depression in Parkinson's disease: evaluating with Zung's Self-Rating Depression Scale.
    Kanda F, Oishi K, Sekiguchi K, Kuga A, Kobessho H, Shirafuji T, Higuchi M, Ishihara H.
    Parkinsonism Relat Disord; 2008 Jan 02; 14(1):19-23. PubMed ID: 17702629
    [Abstract] [Full Text] [Related]

  • 16. Long-term efficacy and safety of pramipexole in advanced Parkinson's disease: results from a European multicenter trial.
    Möller JC, Oertel WH, Köster J, Pezzoli G, Provinciali L.
    Mov Disord; 2005 May 02; 20(5):602-10. PubMed ID: 15726540
    [Abstract] [Full Text] [Related]

  • 17. The use of pramipexole, a novel dopamine (DA) agonist, in advanced Parkinson's disease.
    Molho ES, Factor SA, Weiner WJ, Sanchez-Ramos JR, Singer C, Shulman L, Brown D, Sheldon C.
    J Neural Transm Suppl; 1995 May 02; 45():225-30. PubMed ID: 8748629
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Pramipexole, a nonergot dopamine agonist, is effective against rest tremor in intermediate to advanced Parkinson's disease.
    Künig G, Pogarell O, Möller JC, Delf M, Oertel WH.
    Clin Neuropharmacol; 1999 May 02; 22(5):301-5. PubMed ID: 10516884
    [Abstract] [Full Text] [Related]

  • 20. Double-blind, single-dose, cross-over study of the effects of pramipexole, pergolide, and placebo on rest tremor and UPDRS part III in Parkinson's disease.
    Navan P, Findley LJ, Jeffs JA, Pearce RK, Bain PG.
    Mov Disord; 2003 Feb 02; 18(2):176-80. PubMed ID: 12539211
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.